Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jia Song
Institution:
Tianjin Medical University General Hospital
Observed institutions:
Tianjin Medical University General Hospital,
Tianjin Medical University
ORCID:
0000-0002-7211-8492
Observed ORCID:
0000-0002-7211-8492
OpenAlex ID:
A5048920277
CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2023
·
Jingya Wang
, Ziyi Peng
, et al.
·
Cancer Immunology Research
·
20
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD
2024
·
Lu Zhang
, Qin-hua Liu
, et al.
·
Blood Advances
·
9
Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial
2022
·
Jia Song
, Hui Liu
, et al.
·
Blood
·
7
Zanubrutinib, lenalidomide, rituximab, temozolomide ± methotrexate as first‐line treatment for primary central nervous system lymphoma: A prospective, open‐label, multicentre clinical trial
2026
·
Jia Song
, Huijuan Jiang
, et al.
·
British Journal of Haematology
·
2
PDF
Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial
2024
·
Rong Fu
, Jia Song
, et al.
·
Blood
·
2
PDF
A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe
2022
·
Lu Zhang
, Yujun Dong
, et al.
·
Blood
·
1
Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma
2026
·
Xianghong Zhao
, Zhaoyun Liu
, et al.
·
British Journal of Haematology
PDF
Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real‐world analysis from the Chinese Myeloma Committee
2026
·
Xuelin Dou
, Aijun Liao
, et al.
·
British Journal of Haematology
Supplementary Figures from CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2025
·
Jingya Wang
, Ziyi Peng
, et al.
PDF
Supplementary Tables from CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2025
·
Jingya Wang
, Ziyi Peng
, et al.
PDF
From severe aplastic anemia with TERT variant to Wilson disease - associations or not
2025
·
Tong Chen
, Jia Song
, et al.
·
Annals of Hematology
PDF
Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA
2024
·
Ting Wang
, Donglan Liu
, et al.
·
Blood
Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd
2024
·
Lu Zhang
, Qinhua Liu
, et al.
·
Blood
PDF
Data from CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2023
·
Jingya Wang
, Ziyi Peng
, et al.
Supplementary Figures from CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2023
·
Jingya Wang
, Ziyi Peng
, et al.
PDF
Supplementary Tables from CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2023
·
Jingya Wang
, Ziyi Peng
, et al.
PDF
Data from CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
2023
·
Jingya Wang
, Ziyi Peng
, et al.
Lower expression of the RASSF10 gene induces myeloma cell proliferation due to hypermethylation of the gene promoter in multiple myeloma
2020
·
Jin Chen
, Hui Liu
, et al.
PDF
Show more works
View as search
Works count:
18
Citation count:
41
H-index:
3
I10-index:
1
Year
Topic
Type